EAJAIC

The Eurasian Journal of Anesthesiology and Intensive Care (EAJAIC) is an independent-unbiased, peer-reviewed, "double-blind", and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, differential diagnoses, editorial opinions, letters to the editor, and educational papers in anesthesiology, algology, and intensive care medicine.

EndNote Style
Index
Case Report
Diagnostic challenges in distinguishing TRALI from COVID-19 ARDS
Severe acute respiratory syndrome caused by the SARS-CoV-2 virus (COVID-19) presents with a wide spectrum of clinical manifestations, ranging from asymptomatic infection to acute respiratory distress syndrome (ARDS) and multiorgan failure. Transfusion-related acute lung injury (TRALI) is a serious complication of blood transfusion and is associated with significant morbidity and mortality. A 46-year-old male patient with known chronic kidney disease presented to the emergency department with dyspnea and cough. The patient oxygen saturation was 78%. Laboratory findings revealed elevated white blood cell count, C-reactive protein, and D-dimer levels, along with lymphopenia; hemoglobin level was 7.3 g/dL. Chest computed tomography demonstrated diffuse bilateral ground-glass opacities with focal areas of consolidation. The patient was monitored in the intensive care unit with nasal oxygen therapy. Following blood transfusion for anemia, respiratory status deteriorated at the sixth hour post-transfusion, necessitating endotracheal intubation and initiation of mechanical ventilation. The deterioration in the patient’s respiratory status requiring mechanical ventilation was attributed to several differential diagnoses, including ARDS secondary to COVID-19 or other microorganisms, TRALI, and transfusion-associated circulatory overload (TACO). Bedside chest radiography demonstrated bilateral diffuse pulmonary opacities. Transthoracic echocardiography showed no evidence of left atrial hypertension (LAH), thereby excluding TACO. Accordingly, in our patient, who had risk factors for ARDS but a stable respiratory status for 36 hours before transfusion, the diagnosis of Type II TRALI was considered. The patient was successfully extubated on day 9. Repeated SARS-CoV-2 PCR tests and rapid antibody tests were negative, and blood and urine cultures showed no growth. The patient was discharged to the ward on day 20. TRALI may develop even in the presence of risk factors for ARDS. For the differential diagnosis of TRALI, TACO, and ARDS, a comprehensive evaluation using clinical findings, laboratory parameters, and objective criteria such as echocardiography is recommended.


1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5
2. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574. doi:10.1016/S0140-6736(20)30251-8
3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi:10. 1056/NEJMoa2001017
4. Zengin EN. Research trends and global productivity on mechanical ventilation with the impact of COVID-19: a bibliometric analysis in the period 1980-2021. JHSM. 2022;5(4):1051-1061. doi:10.32322/jhsm.1122437
5. Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-56.e1. doi:10.5694/mja2.50674
6. Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care. 2020;24(1):198. doi:10.1186/s13054-020-02911-9
7. Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-a systematic review and meta-analysis. PLoS One. 2021;16(2):e0246318. doi:10.1371/journal.pone.0246318
8. Zengin EN. Research trends and global productivity on mechanical ventilation with the impact of COVID-19: a bibliometric analysis in the period 1980-2021. JHSM. 2022;5(4):1051-1061. doi:10.32322/jhsm.1122437
9. Vlaar APJ, Toy P, Fung M, et al. A consensus redefinition of transfusion-related acute lung injury. Transfusion. 2019;59(7):2465-2476. doi:10.1111/trf.15311
10. Sivakaanthan A, Swain F, Pahn G, et al. Transfusion-related acute lung injury (TRALI): a retrospective review of reported cases in Queensland, Australia over 20 years. Blood Transfus. 2022;20(6):454-464. doi:10. 2450/2022.0020-22
11. White SK, Schmidt RL, Walker BS, Metcalf RA. The epidemiology of transfusion-related acute lung injury: a scoping review and analysis. Transfusion. 2023;63(1):104-116. doi:10.1111/trf.17185
12. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101(7):1458-1467. doi:10.1172/JCI1841
13. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7
14. Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. doi:10.1172/JCI137244
15. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6): e438-e440. doi:10.1016/S2352-3026(20)30145-9
16. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072-1077. doi: 10.2214/AJR.20.22976
17. Goldberg AD, Kor DJ. State of the art management of transfusion-related acute lung injury (TRALI). Curr Pharm Des. 2012;18(22):3273-3284. doi: 10.2174/1381612811209023273
18. Moore, S. B. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med. 2006;34(5): S114-S117. doi:10.1097/01.CCM.0000214312.20718.3E
Volume 3, Issue 2, 2026
Page : 23-26
_Footer